The resulting transgenic mouse model, Alzheimer’s disease-like pathology with APP, PSEN1, and MAPT transgenes (ADLPAPT), exhibited Aβ accumulation, NFTs, early neuronal loss in the brain, and subsequent memory impairments. The gene discussed is PSEN1; the disease is Alzheimer disease.